Neoantigenics neoantigenics.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

Neoantigenics is focused on developing oncology theranostics (therapeutic plus diagnostic) products, founded on the novel science around oocyte (egg)-associated cancer neoantigens discovered at the University of Virginia. These neoantigens are uniquely expressed in a wide range of urogenital tract cancers – ovarian, uterine, bladder and renal cancers – as well as certain other solid cancers such as aggressive stages of pancreatic cancer and many head-and-neck cancers.

Neoantigenics is focused on developing oncology theranostics (therapeutic plus diagnostic) products, founded on the novel science around oocyte (egg)-associated cancer neoantigens discovered at the University of Virginia. These neoantigens are unique...Show all

Company (Alive / Active)

Phone: 434-984-9723

Fax:

1000 Research Park Blvd
Suite 103
Charlottesville, 22911
Virginia, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Neoantigenics $3.1M Feb 24, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Neoantigenics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)